05:56 PM EDT, 09/30/2024 (MT Newswires) -- Trevi Therapeutics ( TRVI ) said late Monday it has appointed James Cassella as chief development officer.

Cassella previously served as chief development officer at Concert Pharmaceuticals, according to Trevi Therapeutics ( TRVI ).

Trevi said Cassella will replace David Clark, who has stepped down as chief medical officer to help with the care of an immediate family member but will continue to consult for the company.

Price: 3.3693, Change: +0.03, Percent Change: +0.88